Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland

Journal of Cell Science

Volumn 110, Issue 11, 1997, Pages 1261-1268

  Jackson, David ^a   Bresnick, Janine ^a   Rosewell, Ian ^a   Crafton, Tracy ^a   Poulsom, Richard ^a   Stamp, Gordon ^b   Dickson, Clive ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Dominant negative receptor; Fibroblast growth factor receptor; Mammary gland abnormality

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; GROWTH RETARDATION; LACTATION; MAMMARY GLAND; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CASEINS; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; MILK PROTEINS; PHENOTYPE; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RNA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSGENES;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; TUMOR VIRUS;

EID: 0031007802     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Amaya, E., Musci, T. J. and Kirschner, M. W. (1991). Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell 66, 257-270.
2. Ball, R., Friis, R., Schonenberger, C., Doppler, W. and Groner, B. (1988). Prolactin regulation of b-casein gene expression and of a cytosolic 120 kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7, 2089-2095.
3. Banerjee, M., Wood, B., Lin, F. and Crump, L. (1976). Organ culture of whole mammary gland of the mouse. In Tissue Culture Association Manual, vol. 2 (ed. Sandford, K. K.), pp. 457-462. Gaithersberg, MD: TCA.
4. Basilico, C. and Moscatelli, D. (1992). The FGF family of growth-factors and oncogenes. Advan. Cancer Res. 59, 115-165.
5. Buhler, T., Dale, T., Kieback, C., Humphreys, R. and Rosen, J. (1993). Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev. Biol. 155, 87-96.
6. Burgess, W. H. and Maciag, T. (1989). The heparin binding (fibroblast) growth factor family proteins. Annu. Rev. Biochem. 58, 575-606.
7. Chellaiah, A., McEwen, D., Werner, S., Xu, J. and Ornitz, D. (1994). Fibroblast growth factor receptor (FGFR) 3. J. Biol. Chem. 269, 11620-11627.
8. Cheon, H. G., Larochelle, W. J., Bottaro, D. P., Burgess, W. H. and Aaronson, S. A. (1994). High-affinity binding-sites for related fibroblast growth-factor ligands reside within different receptor immunoglobulin-like domains. Proc. Nat. Acad. Sci. USA 91, 989-993.
9. Coleman-Krnacik, S. and Rosen, J. M. (1994). Differential temporal and spatial gene-expression of fibroblast growth-factor family members during mouse mammary-gland development. Mol. Endocrinol. 8, 218-229.
10. Daniel, C. and Silberstein, G. (1987). Postnatal development of the rodent mammary gland. The Mammary Gland: Regulation, and Function. (ed. M. C. Neville and C. W. Daniel), pp. 3-36. New York: Plenum Press.
11. Gavin, B. and McMahon, A. (1992). Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol. Cell. Biol. 12, 2418-2423.
12. Grusby, M., Mitchell, S., Nabavi, N. and Glimcher, L. (1990). Casein expression in cytotoxic T lymphocytes. Proc. Nat. Acad. Sci. USA 87, 6897-6901.
13. Guo, L., Degenstein, L. and Fuchs, E. (1996). Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10, 165-175.
14. Hogan, B., Constantini, F. and Lacy, E. (1986). Manipulating The Mouse Embryo: a Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
15. Jaye, M., Schlessinger, J. and Dionne, C. (1992). Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochem. Biophys. Acta. 1135, 185-199.
16. Jhappan, C., Geiser, A., Kordon, E., Bagheri, D., Hennighausen, L., Roberts, A., Smith, G. and Merlino, G. (1993). Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12, 1835-1845.
17. Johnson, D. and Williams, L. (1993). Structural and functional diversity in the FGF receptor multigene family. Advan. Cancer Res. 60, 1-41.
18. Kashles, O., Yarden, Y., Fisher, R., Ullrich, A. and Schlessinger, J. (1991). A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11, 1454-1463.
19. Kiefer, P., Mathieu, M., Close, M., Peters, G. and Dickson, C. (1993). FGF3 from Xenopus-laevis. EMBO J. 12, 4159-4168.
20. Kitsberg, D. and Leder, P. (1996). Keratinocyte growth-factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 13, 2507-2515.
21. MacArthur, C. A., Shankar, D. B. and Shackleford, G. M. (1995). FGF-8, activated by proviral insertion, cooperates with the wnt-1 transgene in murine mammary tumorigenesis. J. Virol. 69, 2501-2507.
22. Mathieu, M., Kiefer, P., Mason, I. and Dickson, C. (1995). Fibroblast growth-factor (FGF)-3 from Xenopus-laevis (xfgf3) binds with high-affinity to FGF receptor-2. J. Biol. Chem. 270, 6779-6787.
23. Morgenstern, J. P. and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl. Acids Res. 18, 3587-3596.
24. Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P. and Leder, P. (1990). The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9, 907-913.
25. Ornitz, D. M., Cardiff, R. D., Kuo, A. and Leder, P. (1992a). Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J. Nat. Cancer Inst. 84, 887-892.
26. Ornitz, D. M. and Leder, P. (1992). Ligand specificity and heparin dependence of fibroblast growth-factor receptor-1 and receptor-3. J. Biol. Chem. 267, 16305-16311.
27. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E. and Leder, P. (1992b). Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247.
28. Ornitz, D. M., Xu, J. S., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G. X. and Goldfarb, M. (1996). Receptor specificity of the fibroblast growth-factor family. J. Biol. Chem. 271, 15292-15297.
29. Peters, G. (1991). Inappropriate expression of growth factor genes in tumors induced by mouse mammary tumor virus. Semin. Virol. 2, 319-328.
30. Peters, K., Werner, S., Liao, X., Wert, S., Whitsett, J. and Williams, L. (1994). Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J. 13, 3296-3301.
31. Pierce, D. Jr, Johnson, M., Matsui, Y., Robinson, S., Gold, L., Purchio, A., Daniel, C., Hogan, B. and Moses, H. (1993). Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev. 7, 2308-2317.
32. Ruan, W., Newman, C. and Kleinberg, D. (1992). Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc. Nat. Acad. Sci. USA 89, 10872-10876.
33. Senior, P., Critchley, D., Beck, F., Walker, R. and Varley, J. (1988). The localisation of laminin mRNA and protein in the postimplantation embryo and placenta of the mouse: an in situ hybridisation and immunocytochemical study. Development 104, 431-446.
34. Snedeker, S., Brown, C. and DiAugustine, R. (1991). Expression and functional properties of transforming growth factor α and epidermal growth factor during mouse mammary gland ductal morphogenesis. Proc. Nat. Acad. Sci. USA 88, 276-280.
35. Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J. and Lax, I. (1994). Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell-proliferation. Cell 79, 1015-1024.
36. Stamp, G., Fantl, V., Poulsom, R., Jamieson, S., Smith, R., Peters, G. and Dickson, C. (1992). Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Differ. 3, 929-938.
37. Tso, J., Sun, X.-H., Kao, T.-h., Reece, K. and Wu, R. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucl. Acids Res. 13, 2485-2501.
38. Ueno, H., Gunn, M., Dell, K., Tseng, A. and Williams, L. (1992). A truncated form of fibroblast growth-factor receptor-1 inhibits signal transduction by multiple types of fibroblast growth-factor receptor. J. Biol. Chem. 267, 1470-1476.
39. Ulich, T., Yi, E., Cardiff, R., Yin, S., Bikhazi, N., Biltz, R., Morris, C. and Pierce, G. (1994). Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. Am. J. Path. 144, 862-868.
40. Werner, S., Weinberg, W., Liao, X., Peters, K., Blessing, M., Yuspa, S., Weiner, R. and Williams, L. (1993). Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J. 12, 2635-2643.
41. Werner, S., Smola, H., Liao, X., Longaker, M., Krieg, T., Hofschneider, P. and Williams L. (1994). The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266, 819-822.
42. Wilkie, A. O. M., Morrisskay, G. M., Jones, E. Y. and Heath, J. K. (1995). Functions of fibroblast growth-factors and their receptors. Curr Biol. 5, 500-507.
43. Wright, N. A., Poulsom, R., Stamp, G. W. H., Hall, P. A., Jeffery, R. E., Longcroft, J. M., Rio, M., Tomasetto, C. and Chambon, P. (1990). Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162, 279-284.
44. Yamasaki, M., Miyake, A., Tagashira, S. and Itoh, N. (1996). Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J. Biol. Chem. 271, 15918-15921.
45. Yanmin, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K., Birchmeier, C. and Birchmeier, W. (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131, 215-226.
46. Yoshimura, M. and Oka, T. (1989). Isolation and structural analysis of the mouse beta-casein gene. Gene 78, 267-275.
47. Zimmer, Y., Givol, D. and Yayon, A. (1993). Multiple structural elements determine ligand-binding of fibroblast growth-factor receptors - evidence that both ig domain-2 and domain-3 define receptor specificity. J. Biol. Chem. 268, 7899-7903.